Pay in 4 interest-free payments of $6.11 Learn more
Ships within 48 hours · Estimated delivery Oct 12 - Oct 17
Hanno quindi funzioni simili, ma con ambiti di utilizzo leggermente diversi
Luteinizing hormone-releasing hormone (LH-RH) antagonist Cetrorelix inhibits growth of DU-145 human androgen-independent prostate carcinoma in nude mice and suppresses the levels and mRNA expression of IGF-II in tumors
Ipamorelin: synthetic pentapeptide PEPTIDE SEQUENCE CJC-1295 (no DAC): H-Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-Gln-Gln-Gly-Glu-Ser Ipamorelin: Aib-His-D-2-Nal-D-Phe-Lys-NH 2 CHEMICAL STRUCTURE CJC-1295: Ipamorelin: CHEMICAL STRUCTURE CJC-1295 (no DAC): C 152 H 252 N 44 O 42 Ipamorelin: C 38 H 49 N 9 O 5 Mechanism of Action The CJC-1295 (no DAC) + ipamorelin peptide blend stimulates endogenous growth hormone (GH) release by simultaneously activating the growth hormone-releasing hormone receptor (GHRH-R) and the ghrelin/growth hormone secretagogue receptor (GHSR), resulting in synergistic, physiologically pulsatile GH secretion
The mechanism of action includes binding to the GHS-R1a receptor, activation of the Gq/11 protein-dependent signaling pathway and an increase in the intracellular concentration of calcium ions in somatotropes
& Koutalos, Y
US$ 21.89
US$ 22.45
US$ 20.42
US$ 24.00
US$ 26.09
US$ 20.64
